Mesothelioma Illinois
FDA Approves J & JPRD of PANCREAZE NES Johnson & Johnson Pharmaceutical Research and Development (J & JPRD) announced that the U. S. Food and Drug Administration (FDA) approved a new drug aa application (NDA) for PANCREAZE ™ (pancrelipase) delayed-Release capsules for the treatment of of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency, is the inability to properly and spend …